Ally Bridge Group (Ny) LLC Portfolio Holdings

Ally Bridge Group (Ny) LLC

  • $88.1 Million
  • Q4 2024

Ally Bridge Group (Ny) LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $88.1 Million distributed in 30 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Intra Cellular Therapies, Inc. with a value of $12.3M, Tarsus Pharmaceuticals, Inc. with a value of $9.59M, Insmed Inc with a value of $7.9M, Axsome Therapeutics, Inc. with a value of $5.64M, and Xenon Pharmaceuticals Inc. with a value of $5.07M.

Examining the 13F form we can see an decrease of $52.6M in the current position value, from $141M to 88.1M.

Ally Bridge Group (Ny) LLC is based out at New York, NY

Below you can find more details about Ally Bridge Group (Ny) LLC portfolio as well as his latest detailed transactions.

Portfolio value $88.1 Million
Healthcare: $86.6 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$12.1B
$12.3 Million 14.01% of portfolio
147,750
Q4 2024 New
$1.28B
$9.59 Million 10.88% of portfolio
173,144
Q4 2024 Reduced 46.21%
$11B
$7.9 Million 8.96% of portfolio
114,360
Q4 2024 Reduced 24.18%
$5.91B
$5.64 Million 6.4% of portfolio
66,661
Q4 2024 New
$2.47B
$5.07 Million 5.75% of portfolio
129,291
Q4 2024 Reduced 38.95%
$2.17B
$4.91 Million 5.58% of portfolio
116,796
Q4 2024 Reduced 43.91%
$5.51B
$4.87 Million 5.53% of portfolio
55,892
Q4 2024 Reduced 47.31%
$1.5B
$4.83 Million 5.49% of portfolio
90,292
Q4 2024 Reduced 17.02%
$1.57B
$4.1 Million 4.65% of portfolio
244,538
Q4 2024 Reduced 21.02%
$971M
$3.8 Million 4.32% of portfolio
1,074,824
Q4 2024 Reduced 19.25%
$285M
$3.33 Million 3.78% of portfolio
781,489
Q4 2024 Reduced 40.92%
$109M
$3.12 Million 3.55% of portfolio
760,225
Q4 2024 Reduced 38.16%
$210M
$2.59 Million 2.94% of portfolio
348,000
Q4 2024 New
$58.6M
$2.58 Million 2.93% of portfolio
817,939
Q4 2024 New
$509M
$2.44 Million 2.77% of portfolio
317,833
Q4 2024 New
$553M
$2.43 Million 2.76% of portfolio
175,063
Q4 2024 Reduced 35.18%
$3.63B
$1.98 Million 2.24% of portfolio
54,692
Q4 2024 Reduced 75.98%
$12.9M
$1.56 Million 1.77% of portfolio
1,576,762
Q4 2024 Reduced 10.29%
$0
$1.48 Million 1.68% of portfolio
1,592,605
Q3 2024 Added 50.31%
$53.2M
$1.3 Million 1.48% of portfolio
699,730
Q4 2024 New
Dianthus Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Enliven Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 39.66%
Alumis Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 6.42%
Cg Oncology Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 33.89%
Soleno Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 New
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 69.35%
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 38.54%
Mind Medicine Mindmed Inc
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 58.11%
Korro Bio Inc
-
$0 0.0% of portfolio
-
Q4 2024 New

Summary

  • Portfolio
  • No. of Stocks 30
  • Current Value $88.1 Million
  • Prior Value $141 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 14, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 9 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 19 stocks
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email